Aim: To establish close co-operation between partner organisations resulting in capacity building, support for formal education and training of the study staff. This will include the establishment of a framework for future human challenge studies for Shigella and other vaccines. The specific objectives are:

 

• To strengthen and develop capacity in clinical trials and clinical immunology for assessment of immune response to the vaccine in Burkina Faso and Zambia

• To develop know-how and infrastructure for surveillance

• Support South-South and North-South networking and collaboration among consortium partners

To Assess the feasibility of establishing CHIM capabilities and advocate and support initial steps needed to establish CHIM capabilities in Burkina Faso and Zambia

​